CL

Chaim Lebovits

President and Chief Executive Officer

BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics Pipeline

DrugIndicationPhase
NurOwn® (debamestrocel)Amyotrophic Lateral Sclerosis (ALS)Phase 3b
NurOwn® PlatformProgressive Multiple Sclerosis (MS)Phase 2